📰 Rutherford Class News

Rutherford Class News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Rutherford Class. Real-time updates on events, politics, business and more.

Avinger, Inc. (NASDAQ:AVGR) Q2 2023 Earnings Call Transcript

July 28, 2023

Operator: Greetings and welcome to the Avinger Second Quarter 2023 Results Call. At this time, all participants are in a listen-only mode.

Matt Kreps Nabeel Subainati Swayampakula Ramakanth Michael Lichtenberg Jeff Soinski Exchange Commission

Source: insidermonkey.com

Avinger, Inc.: Leading Data on the Treatment of In-Stent Restenosis with Pantheris Presented at Charing Cross International Symposium

April 28, 2023

REDWOOD CITY, CA / ACCESSWIRE / April 28, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for

Redwood City United States City Of United Kingdom Charing Cross Avinger Pantheris

Source: finanznachrichten.de

One-Year BIOPACT Randomized Controlled Trial (RCT) Results Demonstrate Excellent Results for Low-Profile Passeo-18 Lux DCB

November 29, 2022

Head-to-Head Non-Inferiority Study Shows Equivalent Safety and Efficacy of Passeo-18 Lux DCB to In.Pact Admiral DCB in Treatment of Femoropopliteal Lesions

France General Koen Deloose Head Of The Department Vascular Surgery Principal Investigator Paris Vascular Insights Pact Admiral

Source: dicardiology.com

Avinger, Inc.: Ground-Breaking Clinical Data from INSIGHT Trial Presented at VIVA

October 7, 2021

Study Outcomes Demonstrate Safety and Efficacy of Pantheris for Treatment of In-Stent RestenosisREDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical

Redwood City United States Matt Kreps Jon George Avinger Pantheris Mark Weinswig